Trending News
News
News
New Protein Identification Method May Support Drug Discovery
All living cells contains proteins with different functions, depending on the type of cell. Researchers have discovered a way to identify proteins even without looking at their structure.
News
Variant of “Bad Cholesterol” Increases Risk of Recurrent Coronary Heart Disease
Current cholesterol-lowering medications may not be effective at reducing the risk of recurrent CHD – such as a heart attack – due to elevated Lp(a).
News
The Best Drug Combinations To Prevent COVID-19 Recurrence
A groundbreaking machine-learning study has unmasked the best drug combinations to prevent COVID-19 from coming back after an initial infection. It turns out these combos are not the same for every patient.
News
Novel Cancer Immunotherapy Target Identified
Scientists from Japan identify CD69, a glycoprotein present on specific immune cells, as a new target for cancer immunotherapy.
News
Handheld Bioprinter That Prints Personalised Tissues and Organs
A new handheld device can print biocompatible structures in situ, with the potential to revolutionize how physicians treat damaged tissue and organs.
News
Keto Diet Plus Corticosteroids Prevents Cachexia and Slows Tumor Growth in Mice
Researchers have found that pairing a ketogenic diet with common drugs called corticosteroids prevented cachexia in mice with cancer.
News
Pharma Companies Are Capitalizing on Rare Drug Incentives, Study Suggests
According to researchers, drugs used to treat rare conditions are earning pharmaceutical companies almost as much as those marketed to the general public.
News
Small Study Shows Diet–Medication Interactions May Affect Oral Cancer Drug
A small study has identified that the fat content of a meal may affect the bioavailability of an oral cancer drug.
News
New Drug Tested in Non-Hodgkin Lymphoma Lab Models
Researchers have investigated the mechanism of action and therapeutic potential of a new-generation acylfulvene compound in both in vitro and in vivo non-Hodgkin’s lymphoma models.
News
MDMA Approved for Schizophrenia Clinical Trial by FDA
The FDA has approved the use of an MDMA investigational medical product in a small clinical trial to assess its tolerability in a small number of patients with schizophrenia.
Advertisement